Skip to main content

Medications for Irritable Bowel Syndrome with Diarrhea

Other names: Diarrhea-Predominant IBS; Diarrhea-Predominant Irritable Bowel Syndrome; IBS-D

Irritable bowel syndrome with diarrhea (IBS-D), the diarrhea-predominant subtype of IBS, affects up to 40% of people with IBS. It is defined as abdominal pain or discomfort that is generally relieved by passing a bowel motion (defecation). More than 25% of the stools passed are loose or watery (Bristol Stool Form Score of 6-7) and hard or lumpy stools make up less than 25% of the bowel movements.

Drugs used to treat Irritable Bowel Syndrome with Diarrhea

The medications listed below are related to or used in the treatment of this condition.

Filter
Drug name Rating Reviews Activity ? Rx/OTC Pregnancy CSA Alcohol
Xifaxan 5.7 71 reviews for Xifaxan to treat Irritable Bowel Syndrome with Diarrhea
Rx C N
Generic name:
rifaximin systemic
Drug class:
miscellaneous antibiotics
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
Viberzi 6.7 216 reviews for Viberzi to treat Irritable Bowel Syndrome with Diarrhea
Rx 4 X
Generic name:
eluxadoline systemic
Drug class:
peripheral opioid receptor mixed agonists/antagonists
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
Lotronex 9.6 23 reviews for Lotronex to treat Irritable Bowel Syndrome with Diarrhea
Rx B N
Generic name:
alosetron systemic
Drug class:
serotoninergic neuroenteric modulators
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
alosetron 9.6 23 reviews for alosetron to treat Irritable Bowel Syndrome with Diarrhea
Rx B N
Generic name:
alosetron systemic
Brand name:
Lotronex
Drug class:
serotoninergic neuroenteric modulators
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
rifaximin 5.6 76 reviews for rifaximin to treat Irritable Bowel Syndrome with Diarrhea
Rx C N
Generic name:
rifaximin systemic
Brand name:
Xifaxan
Drug class:
miscellaneous antibiotics
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph
eluxadoline 6.7 216 reviews for eluxadoline to treat Irritable Bowel Syndrome with Diarrhea
Rx 4 X
Generic name:
eluxadoline systemic
Brand name:
Viberzi
Drug class:
peripheral opioid receptor mixed agonists/antagonists
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph
EnteraGam 6.4 21 reviews for EnteraGam to treat Irritable Bowel Syndrome with Diarrhea
Rx N U
Generic name:
immune globulin oral systemic
For consumers:
immune globulin oral 6.4 21 reviews for immune globulin oral to treat Irritable Bowel Syndrome with Diarrhea
Rx N U
Generic name:
immune globulin oral systemic
Brand name:
EnteraGam
For consumers:

Frequently asked questions

Learn more about Irritable Bowel Syndrome with Diarrhea

Care guides

Legend

Rating For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective).
Activity Activity is based on recent site visitor activity relative to other medications in the list.
Rx Prescription only.
OTC Over-the-counter.
Rx/OTC Prescription or Over-the-counter.
Off-label This medication may not be approved by the FDA for the treatment of this condition.
EUA An Emergency Use Authorization (EUA) allows the FDA to authorize unapproved medical products or unapproved uses of approved medical products to be used in a declared public health emergency when there are no adequate, approved, and available alternatives.
Expanded Access Expanded Access is a potential pathway for a patient with a serious or immediately life-threatening disease or condition to gain access to an investigational medical product (drug, biologic, or medical device) for treatment outside of clinical trials when no comparable or satisfactory alternative therapy options are available.
Pregnancy Category
A Adequate and well-controlled studies have failed to demonstrate a risk to the fetus in the first trimester of pregnancy (and there is no evidence of risk in later trimesters).
B Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women.
C Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use in pregnant women despite potential risks.
D There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use in pregnant women despite potential risks.
X Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use in pregnant women clearly outweigh potential benefits.
N FDA has not classified the drug.
Controlled Substances Act (CSA) Schedule
M The drug has multiple schedules. The schedule may depend on the exact dosage form or strength of the medication.
U CSA Schedule is unknown.
N Is not subject to the Controlled Substances Act.
1 Has a high potential for abuse. Has no currently accepted medical use in treatment in the United States. There is a lack of accepted safety for use under medical supervision.
2 Has a high potential for abuse. Has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse may lead to severe psychological or physical dependence.
3 Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence.
4 Has a low potential for abuse relative to those in schedule 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3.
5 Has a low potential for abuse relative to those in schedule 4. Has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 4.
Alcohol
X Interacts with Alcohol.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.